Analysts’ Viewpoint on Coated Endotracheal Tube Market Scenario
The COVID-19 pandemic has positively impacted the global coated endotracheal tube market due to the increase in demand for endotracheal tubes for ventilation during the pandemic. Based on strict diagnostic criteria requiring microbiological confirmation, the silver-coated endotracheal tube has been linked to significant reduction in the incidence of ventilator associated pneumonia (VAP). In addition to silver, other metals such as selenium and zinc, as well as their oxides, are incorporated into or coated on polymer surfaces. Silver-coated ETTs prevent biofilm formation, thereby reducing the risk of VAP. Rise in awareness about technologically advanced endotracheal tubes and developments in nanobiotechnology and drug design are likely to propel the global market during the forecast period.
Tracheal tubes play an important role in clinical medical practice. Tracheal intubation is a critical step in establishing an artificial airway and ensuring that the airway is clear, the body's oxygen demand is met, and carbon dioxide is expelled. This technique is used in endotracheal anesthesia, cardiopulmonary resuscitation, and respiratory therapy. Direct application of antimicrobial endotracheal tube is the most common antimicrobial coating method. In order to achieve the antimicrobial effect, the polymer forms a matrix on the coating surface through covalent or ionic bonding. The global coated endotracheal tube market is driven by the rise in incidence of ventilator-associated pneumonia (VAP) along with the adoption of silver-coated ETTs to reduce the incidence of VAP.
Request a sample to get extensive insights into the Coated Endotracheal Tube Market
The ventilator-associated pneumonia (VAP) segment accounted for the largest share of the global coated endotracheal tube market in 2021. The segment is expected to witness strong growth during the forecast period due to the increase in incidence of VAP across the world. Microaspiration of bacteria that colonize the oropharynx and upper airways in critically ill patients is the most common cause of ventilator-associated pneumonia. Nearly 86% of nosocomial pneumonias is ventilator-associated pneumonia, which is caused by mechanical ventilation. Between 250,000 and 300,000 cases are reported each year in the U.S. alone, with an incidence rate of 5 to 10 cases per 1,000 hospital admissions.
Ventilator-associated pneumonia (VAP) is one of the most common ICU-acquired infections, according to a National Library of Medicine study. Depending on the setting and diagnostic criteria, reported incidences range from 5% to 40%. VAP is linked to a longer duration of mechanical ventilation and ICU stay, with higher mortality rates in surgical ICU patients and patients with mid-range severity scores at admission. Hence, prevention of VAP using coated endotracheal tube coating is likely to drive the global market during the forecast period.
Ventilator-associated pneumonia (VAP) is a common healthcare-associated infection (HCAI) that affects 10% to 20% of ICU patients who are mechanically ventilated. ETTs are used by nearly 120 million surgical and intensive care patients globally each year. In participants who require mechanical ventilation for 24 hours or longer, silver-coated ETT appears to show a significant reduction in the risk of VAP, particularly during the first 10 days of mechanical ventilation. Silver has broad-spectrum antibacterial activity. Patients who received a silver-coated endotracheal tube had a statistically significant reduction in the incidence of VAP and a delayed time to VAP occurrence when compared to patients who received a similar, uncoated tube. VAP increases mortality. Several measures are currently in place to prevent VAP in intensive care units (ICUs). Application of the noble metal coating on medical devices has been shown to inhibit bacterial adherence of microorganisms to the surface. Thus, rise in need of mechanical ventilation in ICU patients is expected to drive the global coated endotracheal tube market during the forecast period.
In terms of intubation, the nasotracheal intubation segment held significant market share in 2021. Nasotracheal intubation (NTI) is one of the common methods for inducing anesthesia for head and neck surgeries. NTI involves passing the anesthesia endotracheal tube through the nose, allowing for better isolation and surgical access for intraoral procedures. Nasotracheal intubation is appropriate for patients who require neck immobilization for suspected cervical spine injuries, as well as those who are unable to move their necks due to cervical kyphosis, severe arthritis, or postradiation fibrosis. Furthermore, various complications associated with the tube's nasal passage, such as turbinectomy or retropharyngeal dissection, have been reported. Epistaxis is a common complication of nasotracheal intubation, which has an incidence rate of 18% to 66%.
In terms of end-user, the hospitals segment is projected to account for major share of the global coated endotracheal tube market during the forecast period. Coated endotracheal tubes are commonly used in hospital intensive care units (ICUs) to prevent hospital-acquired infections and other infections. Ventilator-associated pneumonia (VAP) is linked to longer hospital stays, higher mortality rates, and infections caused by multidrug-resistant pathogens. Therefore, preventive measures that could reduce the incidence of VAP in the ICU should be prioritized.
North America held the largest share of around 45% of the global coated endotracheal tube market in 2021. It is projected to be a highly lucrative region of the global market during the forecast period, led by the increase in awareness about early detection of diseases and rise in number of respiratory and infectious diseases. Other factors contributing to North America's dominance are favorable reimbursement policies and high acceptance of advanced technologies. The U.S. dominates the market in North America due to the increase in incidence of hospital-acquired infections (HAIs) in the country. According to the Centers for Disease Control and Prevention (CDC), HAIs are estimated to cause 1.7 million infections and 99,000 deaths in hospitals in the U.S. each year.
The market in Europe is expected to grow rapidly, as market leaders are increasingly collaborating with research institutions and labs to develop new and innovative products. Rise in disposable income, unmet needs of the growing population, rapidly evolving healthcare network, improved reimbursement facilities, and increase in health care awareness are likely to augment the market in Europe.
The global coated endotracheal tube market is consolidated with the presence of small number of leading players. Most of the companies are investing significantly in research & development of coated endotracheal tube products. Expansion of product portfolio and mergers & acquisitions are the key strategies adopted by prominent players in the global coated endotracheal tube market. BD (C. R. Bard), Venner Medical, Sterimed Group, Bactiguard AB, N8 Medical, LLC., Desco Medical India, and Fuji Systems are the key players operating in the global coated endotracheal tube market.
Request a custom report on Coated Endotracheal Tube Market
Each of these players has been profiled in the coated endotracheal tube market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 159.4 Mn |
|
Market Forecast Value in 2031 |
More than US$ 262 Mn |
|
Growth Rate (CAGR) |
5.1% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2020 |
|
Quantitative Units |
US$ Mn for Value & Volume (Units) |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global coated endotracheal tube market was valued at US$ 159.4 Mn in 2021.
The global coated endotracheal tube market is projected to reach more than US$ 262 Mn by 2031.
The global coated endotracheal tube market is anticipated to grow at a CAGR of 5.1% from 2022 to 2031.
Rise in prevalence of respiratory diseases and increase in incidence of ventilator-associated pneumonia (VAP) drive the global coated endotracheal tube market.
North America is expected to account for major share of the global coated endotracheal tube market during the forecast period.
Prominent players in the global coated endotracheal tube market include BD (C. R. Bard), Venner Medical, Sterimed Group, Bactiguard AB, N8 Medical, LLC., Desco Medical India, and Fuji Systems.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Coated Endotracheal Tube Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Coated Endotracheal Tube Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Technological Advancements
5.2. Key Industry Events (partnership, merger & acquisition, etc.)
5.3. COVID-19 Impact Analysis
5.4. Insights on Healthcare Associated Infection (HAI)
6. Global Coated Endotracheal Tube Market Analysis and Forecast, by Intubation
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Intubation, 2017–2031
6.3.1. Orotracheal Intubation
6.3.2. Nasotracheal Intubation
6.4. Market Attractiveness Analysis, by Intubation
7. Global Coated Endotracheal Tube Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Anesthesia
7.3.2. Congenital Respiratory Disorder
7.3.3. Ventilator-associated Pneumonia (VAP)
7.3.4. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Coated Endotracheal Tube Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Ambulatory Surgical Centers
8.4. Market Attractiveness Analysis, by End-user
9. Global Coated Endotracheal Tube Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Coated Endotracheal Tube Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Intubation, 2017–2031
10.2.1. Orotracheal Intubation
10.2.2. Nasotracheal Intubation
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Anesthesia
10.3.2. Congenital Respiratory Disorder
10.3.3. Ventilator-associated Pneumonia (VAP)
10.3.4. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Ambulatory Surgical Centers
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Intubation
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Coated Endotracheal Tube Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Intubation, 2017–2031
11.2.1. Orotracheal Intubation
11.2.2. Nasotracheal Intubation
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Anesthesia
11.3.2. Congenital Respiratory Disorder
11.3.3. Ventilator-associated Pneumonia (VAP)
11.3.4. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Ambulatory Surgical Centers
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Intubation
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Coated Endotracheal Tube Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Intubation, 2017–2031
12.2.1. Orotracheal Intubation
12.2.2. Nasotracheal Intubation
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Anesthesia
12.3.2. Congenital Respiratory Disorder
12.3.3. Ventilator-associated Pneumonia (VAP)
12.3.4. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Ambulatory Surgical Centers
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Intubation
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Coated Endotracheal Tube Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Intubation, 2017–2031
13.2.1. Orotracheal Intubation
13.2.2. Nasotracheal Intubation
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Anesthesia
13.3.2. Congenital Respiratory Disorder
13.3.3. Ventilator-associated Pneumonia (VAP)
13.3.4. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Ambulatory Surgical Centers
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Intubation
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Coated Endotracheal Tube Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value & Forecast, by Intubation, 2017–2031
14.2.1. Orotracheal Intubation
14.2.2. Nasotracheal Intubation
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Anesthesia
14.3.2. Congenital Respiratory Disorder
14.3.3. Ventilator-associated Pneumonia (VAP)
14.3.4. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Ambulatory Surgical Centers
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Intubation
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. BD (C. R. Bard)
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Venner Medical
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Sterimed Group
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Bactiguard AB
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. N8 Medical, LLC.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Desco Medical India
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Fuji Systems
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Other prominent players
List of Table
Table 01: Global Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by Intubation, 2017–2031
Table 02: Global Coated Endotracheal Tube Market Volume (Units) Forecast, by Intubation, 2017–2031
Table 03: Global Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 04: Global Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 05: Global Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by Intubation, 2017–2031
Table 08: North America Coated Endotracheal Tube Market Volume (Units) Forecast, by Intubation, 2017–2031
Table 09: North America Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 10: North America Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by Intubation, 2017–2031
Table 13: Europe Coated Endotracheal Tube Market Volume (Units) Forecast, by Intubation, 2017–2031
Table 14: Europe Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 15: Europe Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by Intubation, 2017–2031
Table 18: Asia Pacific Coated Endotracheal Tube Market Volume (Units) Forecast, by Intubation, 2017–2031
Table 19: Asia Pacific Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Asia Pacific Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Latin America Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Latin America Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by Intubation, 2017–2031
Table 23: Latin America Coated Endotracheal Tube Market Volume (Units) Forecast, by Intubation, 2017–2031
Table 24: Latin America Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 25: Latin America Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 26: Middle East & Africa Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 27: Middle East & Africa Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by Intubation, 2017–2031
Table 28: Middle East & Africa Coated Endotracheal Tube Market Volume (Units) Forecast, by Intubation, 2017–2031
Table 29: Middle East & Africa Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 30: Middle East & Africa Coated Endotracheal Tube Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Coated Endotracheal Tube Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Coated Endotracheal Tube Market Value Share, by Intubation, 2021
Figure 03: Global Coated Endotracheal Tube Market Value Share, by Application, 2021
Figure 04: Global Coated Endotracheal Tube Market Value Share, by End-user, 2021
Figure 05: Global Coated Endotracheal Tube Market Value Share, by Region, 2021
Figure 06: Global Coated Endotracheal Tube Market Value Share Analysis, by Intubation, 2021 and 2031
Figure 07: Global Coated Endotracheal Tube Market Revenue (US$ Mn), by Orotracheal Intubation, 2017–2031
Figure 08: Global Coated Endotracheal Tube Market Revenue (US$ Mn), by Nasotracheal Intubation, 2017–2031
Figure 09: Global Coated Endotracheal Tube Market Attractiveness Analysis, by Intubation, 2022-2031
Figure 10: Global Coated Endotracheal Tube Market Value Share Analysis, by Application, 2021 and 2031
Figure 11: Global Coated Endotracheal Tube Market Revenue (US$ Mn), by Anesthesia, 2017–2031
Figure 12: Global Coated Endotracheal Tube Market Revenue (US$ Mn), by Congenital Respiratory Disorder, 2017–2031
Figure 13: Global Coated Endotracheal Tube Market Revenue (US$ Mn), Ventilator-associated Pneumonia (VAP), 2017–2031
Figure 14: Global Coated Endotracheal Tube Market Revenue (US$ Mn), by Others, 2017–2031
Figure 15: Global Coated Endotracheal Tube Market Attractiveness Analysis, by Application, 2022-2031
Figure 16: Global Coated Endotracheal Tube Market Value Share Analysis, by End-user, 2021 and 2031
Figure 17: Global Coated Endotracheal Tube Market Revenue (US$ Mn), by Hospitals, 2017–2031
Figure 18: Global Coated Endotracheal Tube Market Revenue (US$ Mn), by Clinics, 2017–2031
Figure 19: Global Coated Endotracheal Tube Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2017–2031
Figure 20: Global Coated Endotracheal Tube Market Attractiveness Analysis, by End-user, 2022-2031
Figure 21: Global Coated Endotracheal Tube Market Value Share Analysis, by Region, 2021 and 2031
Figure 22: Global Coated Endotracheal Tube Market Attractiveness Analysis, by Region, 2022-2031
Figure 23: North America Coated Endotracheal Tube Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 24: North America Coated Endotracheal Tube Market Value Share (%), by Country, 2021 and 2031
Figure 25: North America Coated Endotracheal Tube Market Attractiveness Analysis, by Country, 2022–2031
Figure 26: North America Coated Endotracheal Tube Market Value Share Analysis, by Intubation, 2021 and 2031
Figure 27: North America Coated Endotracheal Tube Market Attractiveness Analysis, by Intubation, 2022–2031
Figure 28: North America Coated Endotracheal Tube Market Value Share Analysis, by Application, 2021 and 2031
Figure 29: North America Coated Endotracheal Tube Market Attractiveness Analysis, by Application, 2022–2031
Figure 30: North America Coated Endotracheal Tube Market Value Share Analysis, by End-user, 2021 and 2031
Figure 31: North America Coated Endotracheal Tube Market Attractiveness Analysis, by End-user, 2022–2031
Figure 32: Europe Coated Endotracheal Tube Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 33: Europe Coated Endotracheal Tube Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 37: Europe Coated Endotracheal Tube Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 34: Europe Coated Endotracheal Tube Market Value Share Analysis, by Intubation, 2021 and 2031
Figure 35: Europe Coated Endotracheal Tube Market Attractiveness Analysis, by Intubation, 2022–2031
Figure 36: Europe Coated Endotracheal Tube Market Value Share Analysis, by Application, 2021 and 2031
Figure 37: Europe Coated Endotracheal Tube Market Attractiveness Analysis, by Application, 2022–2031
Figure 38: Europe Coated Endotracheal Tube Market Value Share Analysis, by End-user, 2021 and 2031
Figure 39: Europe Coated Endotracheal Tube Market Attractiveness Analysis, by End-user, 2022–2031
Figure 40: Asia Pacific Coated Endotracheal Tube Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 41: Asia Pacific Coated Endotracheal Tube Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 42: Asia Pacific Coated Endotracheal Tube Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 42: Asia Pacific Coated Endotracheal Tube Market Value Share Analysis, by Intubation, 2021 and 2031
Figure 48: Asia Pacific Coated Endotracheal Tube Market Attractiveness Analysis, by Intubation, 2022–2031
Figure 49: Asia Pacific Coated Endotracheal Tube Market Value Share Analysis, by Application, 2021 and 2031
Figure 50: Asia Pacific Coated Endotracheal Tube Market Attractiveness Analysis, by Application, 2022–2031
Figure 51: Asia Pacific Coated Endotracheal Tube Market Value Share Analysis, by End-user, 2021 and 2031
Figure 52: Asia Pacific Coated Endotracheal Tube Market Attractiveness Analysis, by End-user, 2022–2031
Figure 53: Latin America Coated Endotracheal Tube Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 54: Latin America Coated Endotracheal Tube Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 55: Latin America Coated Endotracheal Tube Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 56: Latin America Coated Endotracheal Tube Market Value Share Analysis, by Intubation, 2021 and 2031
Figure 57: Latin America Coated Endotracheal Tube Market Attractiveness Analysis, by Intubation, 2022–2031
Figure 58: Latin America Coated Endotracheal Tube Market Value Share Analysis, by Application, 2021 and 2031
Figure 59: Latin America Coated Endotracheal Tube Market Attractiveness Analysis, by Application, 2022–2031
Figure 60: Latin America Coated Endotracheal Tube Market Value Share Analysis, by End-user, 2021 and 2031
Figure 61: Latin America Coated Endotracheal Tube Market Attractiveness Analysis, by End-user, 2022–2031
Figure 62: Middle East & Africa Coated Endotracheal Tube Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 63: Middle East & Africa Coated Endotracheal Tube Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 64: Middle East & Africa Coated Endotracheal Tube Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 65: Middle East & Africa Coated Endotracheal Tube Market Value Share Analysis, by Intubation, 2021 and 2031
Figure 66: Middle East & Africa Coated Endotracheal Tube Market Attractiveness Analysis, by Intubation, 2022–2031
Figure 67: Middle East & Africa Coated Endotracheal Tube Market Value Share Analysis, by Application, 2021 and 2031
Figure 68: Middle East & Africa Coated Endotracheal Tube Market Attractiveness Analysis, by Application, 2022–2031
Figure 69: Middle East & Africa Coated Endotracheal Tube Market Value Share Analysis, by End-user, 2021 and 2031
Figure 70: Middle East & Africa Coated Endotracheal Tube Market Attractiveness Analysis, by End-user, 2022–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Coated Endotracheal Tube Market
*86 figures and 60 tables includes